| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年9月 |
Neuromodulation Market – Global Forecast To 2030
ニューロモジュレーション市場 – 技術（内部、外部）、刺激の種類（脊髄、脳深部、迷走神経刺激）、用途（虚血、うつ病、てんかん、肥満）、エンドユーザー（病院、ASC、クリニック）および地域別 – 2030年までの世界予測
本レポートは、ニューロモジュレーション市場を、技術、刺激の種類、用途、エンドユーザー、および国別に分析しています。また、市場の成長に影響を与える推進要因、制約要因、機会、課題といった要因に加え、市場リーダーの競争環境についても詳細に分析しています。さらに、ミクロ市場をそれぞれの成長トレンドに沿って分析し、5つの主要地域とそれぞれの国における市場セグメントの収益予測も示しています。
本レポートは、既存企業と中小規模企業の両方にとって、市場動向の理解を深め、ひいては市場シェアの拡大に貢献します。本レポートをご購入いただいた企業は、以下に挙げる戦略のいずれか、または組み合わせて活用することで、市場における地位を強化できます。
世界のニューロモジュレーション市場は、予測期間中に9.4%のCAGRで成長し、2025年の68億1,000万米ドルから2030年には106億8,000万米ドルに達すると予測されています。
ニューロモジュレーション市場は、神経疾患の有病率の上昇、新たなニューロモジュレーション技術の開発、そして高齢化人口の増加により拡大しており、これらはすべて市場の成長に寄与しています。しかし、ニューロモジュレーション治療の高額な費用が市場の成長を阻害する可能性もあります。
The global neuromodulation market is projected to reach USD 10.68 billion by 2030 from USD 6.81 billion in 2025, at a CAGR of 9.4% during the forecast period.
The neuromodulation market is expanding due to the rising prevalence of neurological disorders, the development of new neuromodulation technologies, and the increasing geriatric population, all of which contribute to market growth. Additionally, the high cost of neuromodulation procedures may limit the market growth.
Neuromodulation Market – Global Forecast To 2030
The major players operating in the neuromodulation market are Medtronic (US), Boston Scientific Corporation (US), Abbott (US), LivaNova PLC (UK), Nevro Corp (US), NeuroPace, Inc. (US), Bioventus (US), electroCore, Inc. (US), Helius Medical Technologies, Inc. (US), and Neuronetics (US).
Research Coverage
This report examines the neuromodulation market based on technology, stimulation type, application, end user, and country. It also analyzes factors such as drivers, restraints, opportunities, and challenges that influence market growth, along with details of the competitive landscape for market leaders. Additionally, the report studies micro markets according to their individual growth trends. It forecasts the revenue of market segments across five major regions and their respective countries.
Reasons to Buy the Report
The report will help both established and smaller firms to understand market trends, which, in turn, will assist them in gaining a larger market share. Companies purchasing the report can use one or a combination of the strategies listed below to strengthen their market position.
This report provides insights into the following pointers:
Analysis of key drivers (rising prevalence of neurological disorders and nerve injuries, rising geriatric population and subsequent growth in prevalence of neurological disorders, rising government support and funding for neurological disorders, increasing focus on development of advanced neuromodulation and neurostimulation technologies, increasing collaborations among device manufacturers, healthcare providers, and research institutions to develop neuromodulation devices, and availability of reimbursements for neuromodulation devices), restraints (high cost of neuromodulation procedures, preference for drug therapies over neuromodulation products, and adverse effects and complications associated with neuromodulation devices), opportunities (large population and increasing healthcare expenditure in emerging economies, and widening application scope of neuromodulation), challenges (stringent regulatory framework and time-consuming approval processes for neuromodulation and neurostimulation devices, and shortage of trained professionals)
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the neuromodulation market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the neuromodulation market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the neuromodulation market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players